Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
LUMI ESLT ISTA OSEM Outsourcing Impulse Small Growth ISP 
United States  USA  |  Check Insiders


Processing
Collecting data for CRM and MRK ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 salesforce.com inc  vs   Merck & Co. Inc.
 Compare Fundamentals  
Daily Returns (%)
MRK   CRM   
 
Considering 30-days investment horizon, salesforce inc is expected to generate 1.0 times more return on investment than Merck. However, salesforce inc is as risky as Merck. It trades about 0.57 of its potential returns per unit of risk. Merck Co Inc is currently generating about -0.13 per unit of risk. If you would invest  4,032  in salesforce inc on April 19, 2013 and sell it today you would earn a total of  647  from holding salesforce inc or generate 16.05% return on investment over 30 days.

Diversification

Average diversification
Overlapping area represents amount of risk that can be diversified away by holding salesforce.com inc and Merck & Co. Inc. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.12
Parameters
Time Period1 Month [change]
DirectionPositive MRK Moved Up vs CRM
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between CRM and MRK with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between CRM and MRK to your reader
 
Share Correlation between CRM and MRK 
Find Opportunities
 
Predicted Return Density
 
Returns   
MRK   CRM   

salesforce inc

 
    
Salesforce
Performance
30
Out Of
100
Over 30
Days
70% of all equities and portfolios perform better than salesforce inc. Compared with the overall equity markets, risk-adjusted returns on investments in salesforce inc are ranked lower than 30 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for Salesforce

Microsoft Corporation vs. salesforce inc
Oracle Corporation vs. salesforce inc
SAP AG vs. salesforce inc
Adobe Systems Inc vs. salesforce inc
Intuit Inc vs. salesforce inc
CA Technologies vs. salesforce inc
Red Hat Inc vs. salesforce inc
VeriSign Inc vs. salesforce inc
BMC Software Inc vs. salesforce inc
  

Merck Co Inc

 
    
Merck
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Merck Co Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match ups for Merck

Johnson Johnson vs. Merck Co Inc
Pfizer Inc vs. Merck Co Inc
Novartis AG vs. Merck Co Inc
Sanofi vs. Merck Co Inc
GlaxoSmithKline plc vs. Merck Co Inc
BristolMyers Squibb Company vs. Merck Co Inc
AstraZeneca PLC vs. Merck Co Inc
Eli Lilly and Company vs. Merck Co Inc
Impax Laboratories Inc vs. Merck Co Inc


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium